Monthly Program
Meeting Details
September 09, 2008
WPI Campus Center - Odeum Room
Doors open: 5:30 p.m.
Meeting: 6:00 - 9 p.m.
Cost: $15 members, $25 non-members
Pre-registration now available
September 9, 2008
Life Sciences Leader Opens New Season
Susan Windham-Bannister
There’s a biomedical boom in the Worcester area according to recent research, and Governor Deval Patrick’s signature on a $1 billion life sciences bill last June can only fuel growth in this industry. The impact of this new funding to support both research and investment in life sciences will be the subject of the Tuesday, September 9 keynote address by Susan Windham-Bannister, PhD, President and CEO of the Massachusetts Life Sciences Center (MLSC), the primary agency tasked with realizing the governor’s vision for this life sciences initiative. The 18th season of the WPI Venture Forum will open with discussion of a powerful subject for the region’s future.
Case Presentation
RXi Pharmaceuticals
Tod Woolf
RXi Pharmaceuticals is a discovery-stage biopharmaceutical company pursuing the development and potential commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases. President and Chief Executive Officer Tod Woolf, PhD along with his accomplished scientific advisors, including Dr. Craig Mello, believes the company is well positioned to compete successfully in the RNAi-based therapeutics market. Woolf has authored 40 patent applications and scientific publications and has twenty years of experience developing and commercializing innovative biomedical technologies.
Maintained by webmaster@wpi.eduLast modified: Sep 04, 2008, 10:27 EDT
